Advertisement

Topics

BRIEF-AGTC files investigational NDA for treatment of achromatopsia

12:25 EDT 19 Oct 2016 | Reuters

* AGTC files investigational new drug application for the treatment of Achromatopsia caused by mutations in the CNGA3 gene Source text for Eikon: Further company coverage:

Original Article: BRIEF-AGTC files investigational NDA for treatment of achromatopsia

NEXT ARTICLE

More From BioPortfolio on "BRIEF-AGTC files investigational NDA for treatment of achromatopsia"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...